In This Article:
-
Revenue: $4.5 million for Q2 FY2025, compared to $4.8 million in Q2 FY2024.
-
Gross Margin: 24% for Q2 FY2025, down from 30% in Q2 FY2024.
-
Net Loss: $910,000 for Q2 FY2025, compared to $704,000 in Q2 FY2024.
-
Adjusted EBITDA: Negative $555,000 for Q2 FY2025, compared to negative $269,000 in Q2 FY2024.
-
Production Revenue Increase: 42% increase from Q1 to Q2 FY2025.
-
SG&A Expenses: $1.7 million for Q2 FY2025, a decrease from $1.9 million in Q2 FY2024.
-
R&D Expenses: Increased to $318,000 for Q2 FY2025 from $222,000 in Q2 FY2024.
-
Cash Balance: Approximately $200,000 as of December 31, 2024.
-
Forecasted Revenue: At least $5 million for Q3 FY2025 and $6 million for Q4 FY2025.
Release Date: February 13, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
-
Precision Optics Corp Inc (NASDAQ:POCI) reported a 42% increase in production from Q1 to Q2, driven by their single-use cystoscope and defense aerospace programs.
-
The company launched its Unity imaging platform, which is expected to accelerate time to market and reduce development risks for endoscopic systems.
-
POCI has a strong backlog and expects continued growth in the second half of fiscal 2025, with Q4 projected to reach a record $6 million in revenue.
-
The company is well-positioned to benefit from the growing single-use endoscope market, which is estimated to grow at 20% annually.
-
POCI is expanding its clean room space and workforce to meet increasing demand, aiming to double output for key programs in the coming months.
Negative Points
-
Revenue for the second quarter was $4.5 million, lower than the expected $5 million, due to delays in product development and production ramp-up.
-
Gross margins decreased to 24% from 30% in the same quarter last year, impacted by non-billable projects and lower sales volume.
-
The company reported a net loss of $910,000 for the quarter, compared to a $704,000 net loss in the previous year.
-
Adjusted EBITA was negative $555,000, worse than the negative $269,000 reported last year.
-
Capacity constraints have limited revenue growth, requiring significant efforts to expand clean room space and increase workforce.
Q & A Highlights
Q: Can you provide an update on the defense contracts, especially those with specification problems that seemed to have stalled and then started back up? Are there follow-up contracts on any of these? A: Joseph Forkey, CEO: We have two significant defense aerospace programs in production. One has been running steadily at $2 million to $2.5 million annually and is expected to continue indefinitely. The second, newer program faced a temporary halt due to a measurement error but has resumed. We anticipate reaching a $3 million to $4 million run rate by the end of the fiscal year, with expectations for continued reorders.